Navigation Links
Markets for PCR, DNA Microarray, DNA Sequencing, Mass Spectrometry and Flow Cytometry to Exceed $50 billion by 2015
Date:11/5/2012

FARMINGTON, Conn., Nov. 5, 2012 /PRNewswire-iReach/ -- Techniques such as PCR, DNA microarray, DNA sequencing, mass spectrometry and flow cytometry have driven discoveries that have changed our understanding of the world. By 2015, the combined global markets for these five areas are expected to exceed $50 billion.

(Photo: http://photos.prnewswire.com/prnh/20121105/CG06410

From now until December 31, Global Information Inc (GII), in exclusive partnership with our premium research partner BioPharm Reports,, is offering a special discount on all BioPharm market research reports, forecasts, and studies. How will your organization use the critical information contained within these reports to support growth and sales strategies and seize market opportunities in the life sciences field?

Life Science Software: Markets and Opportunities

This report is the result of six life science studies examining the use of specialist software and databases related to the conduct of PCR, DNA sequencing, DNA microarray, flow cytometry, mass spectrometry and disease biomarker studies. In total, 2,200 end-users in 70 countries participated in these studies. This is an excellent study for software developers and vendors to identify market opportunities in the life science field.

The major components of the report are as follows: breakdown of end-user practices in use of life science software and databases to conduct studies of PCR, DNA microarray, DNA sequencing, mass spectrometry, flow cytometry, and disease biomarker; breakdown of end-user practices by field (e.g. biotech, hospital, defence, pharmaceuticals, food and drink); breakdown by region, including Europe, North America, Asia and RoW countries; list of participating organizations and anticipated growth; and estimates of global market sizes of software and databases related to the respective life science fields.

An Executive Summary for this report and free sample pages from the full document are available at http://www.giiresearch.com/report/bph251023-life-science-software-markets-opportunities.html

DNA Microarray 2012: A Focus on Sales Growth

Based on the prevailing and emerging market conditions in the DNA microarray field, this report was created to assist marketing and sales with the identification of new opportunities. The analysis and report findings provide a "focus on sales growth" to developers and vendors in the microarray field and the changes driving these developments.

Market areas covered in this study include: routine use, suppliers, methods, applications, preferred companies, products, strengths, weaknesses, financial budgets, budget breakdown, future budget breakdown, future budgets, consumables, quality control, challenges, innovation, recent innovations, future innovation, biomarkers, organizations, fields, bioinformatics software, purpose, samples and sample preparation.

An Executive Summary for this report and free sample pages from the full document are available at http://www.giiresearch.com/report/bph250862-dna-microarray-focus-on-sales-growth.html

Life Science Consumables: Markets and Opportunities

Techniques such as PCR, DNA microarray, DNA sequencing, mass spectrometry and flow cytometry have driven discoveries that have changed our understanding of the world. This report identifies the markets and opportunities within the life science consumables field related to PCR, DNA sequencing, DNA microarray, flow cytometry, mass spectrometry and disease biomarkers.

An Executive Summary for this report and free sample pages from the full document are available at http://www.giiresearch.com/report/bph251024-life-science-consumables-markets-opportunities.html

About Global Information Inc. Global Information (GII) (http://www.giiresearch.com) is an information service company partnering with over 300 research companies around the world. Global Information has been in the business of distributing technical and market research for more than 25 years. Expanded from its original headquarters in Japan, Global Information now has offices in Korea, Taiwan, Singapore, Europe and the United States.

Media Contact: Jeremy Palaia Global Information, Inc., 1-860-674-8796, Press@gii.co.jp

News distributed by PR Newswire iReach: https://ireach.prnewswire.com


'/>"/>
SOURCE Global Information, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related biology news :

1. New Market Forecasts Available for Critical Global Biotechnology Testing and Screening Markets: Molecular Diagnostics, Hematology, Clinical Chemistry and Nucleic Acid Testing
2. The International Society for Advancement of Cytometry presented its 2012 awards at CYTO 2012
3. Costs for changing pollution criteria in Florida waters likely to exceed EPA estimates
4. Natures billion-year-old battery key to storing energy
5. MEMS Market Triples 2009-2011, to Reach $5.4 Billion in 2017
6. Palladium-gold nanoparticles clean TCE a billion times faster than iron filings
7. Global Biobanking Market Projected to Increase by 30% to Reach $183 Billion by 2015
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/29/2016)... Nearly one billion matches per second with DERMALOG,s high-speed AFIS    ... ... DERMALOG is Germany's largest Multi-Biometric supplier: The company's Fingerprint ... ... Multi-Biometric supplier: The company's Fingerprint Identification System is part of an efficient ...
(Date:11/21/2016)... Nov. 21, 2016   Neurotechnology , a ... technologies, today announced that the MegaMatcher On Card ... submitted for the NIST Minutiae Interoperability Exchange ... the mandatory steps of the evaluation protocol. ... continuing test of fingerprint templates used to establish ...
(Date:11/15/2016)... 2016  Synthetic Biologics, Inc. (NYSE MKT: SYN), ... the gut microbiome, today announced the pricing of ... its common stock and warrants to purchase 50,000,000 ... to the public of $1.00 per share and ... the offering, excluding the proceeds, if any from ...
Breaking Biology News(10 mins):
(Date:12/8/2016)... Soligenix, Inc. (OTCQB: SNGX) (Soligenix or the ... commercializing products to treat rare diseases where there is ... be hosting an Investor Webcast Event Friday, December 16, ... innate defense regulators (IDRs) as a new drug class, ... the recently announced and published Phase 2 clinical data ...
(Date:12/8/2016)... HOWELL, N.J. , Dec. 8, 2016 /PRNewswire/ ... aquatic augmentation remediation technologies and selected NewTechBio,s NT-MAX ... , a microbial based beneficial bacteria, in conjunction ... Inc., to correct deficiencies with National Pollutant Discharge ... basin 281-8H has experienced a steady history of ...
(Date:12/8/2016)... 2016  Partnering to fuel Philadelphia,s ... of Southeastern Pennsylvania (" Ben ... of Independence Blue Cross; and Safeguard Scientifics ("Safeguard") (NYSE: ... a $6 million funding initiative over a four year ... Responding to a burgeoning economic vitality in digital health, ...
(Date:12/7/2016)... ... December 07, 2016 , ... ... phase I/II dose escalation and expansion clinical trial for its lead drug candidate, ... The purpose of the trial was to determine the safety, antitumor activity, and ...
Breaking Biology Technology: